Background Isocitrate dehydrogenase 1 (IDH1) mutation is a key molecular marker in gliomas and is generally associated with favorable prognosis. However, its dynamic changes and prognostic significance during tumor recurrence remain incompletely understood. Methods We conducted a retrospective analysis of 42 patients w...
Wei Yu, Si-Yu Guo, Bei-Bei Liu et al.· Human Mutation· 0 citations
ABSTRACT Background and Aims Tumors actively remodel the tumor microenvironment (TME) to foster therapy resistance. However, the underlying mechanisms remain poorly defined. This study aims to characterize how colorectal cancer (CRC) cells drive TME remodeling to promote radioresistance. Methods A radioresistant CRC ce...
Yimin Fang, Jinglin Zhu, Qian Xiao et al.· Advancement of science· 0 citations
This review critically evaluates recent mechanistic advances in CDK/cyclin biology and their pathological dysregulation across malignancies and highlights emerging approaches including proteolysis‐targeting chimeras, HSP90‐mediated targeting chimeras, hydrophobic tagging, molecular glues, and autophagy‐tethering compou...